批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2024/12/03 |
SUPPL-44(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/04/27 |
SUPPL-41(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2018/06/05 |
SUPPL-40(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2018/01/18 |
SUPPL-39(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/12/30 |
SUPPL-37(补充) |
Approval |
Labeling |
STANDARD
|
|
Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs. |
2016/07/27 |
SUPPL-36(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/12/19 |
SUPPL-35(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/06/18 |
SUPPL-33(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2013/12/16 |
SUPPL-34(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/12/16 |
SUPPL-32(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/03/28 |
SUPPL-31(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2010/12/23 |
SUPPL-28(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2009/08/06 |
SUPPL-25(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2008/03/27 |
SUPPL-22(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2008/03/13 |
SUPPL-23(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2005/08/17 |
SUPPL-20(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2005/05/25 |
SUPPL-18(补充) |
Approval |
Efficacy |
UNKNOWN
|
|
|
2004/06/04 |
SUPPL-16(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/06/18 |
SUPPL-13(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2002/06/05 |
SUPPL-14(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2001/07/23 |
SUPPL-10(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2001/02/06 |
SUPPL-7(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2001/01/29 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2000/05/23 |
SUPPL-5(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2000/03/31 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1999/10/12 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1996/06/21 |
ORIG-1(原始申请) |
Approval |
Type 1 - New Molecular Entity |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
001 |
4943569 |
2010/06/21 |
Y |
Y |
U-282 |
|
|
PDF格式 | **本条是由Drugfuture回溯的历史信息** |
003 |
4943569 |
2010/06/21 |
Y |
Y |
U-282 |
|
|
PDF格式 | **本条是由Drugfuture回溯的历史信息** |
与本品治疗等效的药品
活性成分:MEROPENEM 剂型/给药途径:INJECTABLE;INJECTION 规格:1GM/VIAL 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
050706 |
001 |
NDA |
MERREM |
MEROPENEM |
INJECTABLE;INJECTION |
1GM/VIAL |
Prescription |
Yes |
Yes |
AP |
1996/06/21
|
PFIZER |
091404 |
002 |
ANDA |
MEROPENEM |
MEROPENEM |
INJECTABLE;INJECTION |
1GM/VIAL |
Prescription |
No |
No |
AP |
2011/10/26
|
ACS DOBFAR |
204854 |
002 |
ANDA |
MEROPENEM |
MEROPENEM |
INJECTABLE;INJECTION |
1GM/VIAL |
Discontinued |
No |
No |
AP |
2015/12/18
|
DAEWOONG PHARM CO |
205883 |
002 |
ANDA |
MEROPENEM |
MEROPENEM |
INJECTABLE;INJECTION |
1GM/VIAL |
Prescription |
No |
No |
AP |
2016/04/12
|
AMNEAL PHARMS |
206086 |
002 |
ANDA |
MEROPENEM |
MEROPENEM |
INJECTABLE;INJECTION |
1GM/VIAL |
Prescription |
No |
No |
AP |
2016/04/19
|
SAVIOR LIFETEC CORP |
206141 |
002 |
ANDA |
MEROPENEM |
MEROPENEM |
INJECTABLE;INJECTION |
1GM/VIAL |
Prescription |
No |
No |
AP |
2016/06/08
|
GLAND |
204139 |
002 |
ANDA |
MEROPENEM |
MEROPENEM |
INJECTABLE;INJECTION |
1GM/VIAL |
Prescription |
No |
No |
AP |
2016/06/09
|
ACS DOBFAR SPA |
205835 |
002 |
ANDA |
MEROPENEM |
MEROPENEM |
INJECTABLE;INJECTION |
1GM/VIAL |
Prescription |
No |
No |
AP |
2017/03/27
|
EUGIA PHARMA |
210773 |
002 |
ANDA |
MEROPENEM |
MEROPENEM |
INJECTABLE;INJECTION |
1GM/VIAL |
Prescription |
No |
No |
AP |
2019/08/16
|
HQ SPCLT PHARMA |
216154 |
002 |
ANDA |
MEROPENEM |
MEROPENEM |
INJECTABLE;INJECTION |
1GM/VIAL |
Prescription |
No |
No |
AP |
2022/08/18
|
BROOKS STERISCIENCE |
216424 |
002 |
ANDA |
MEROPENEM |
MEROPENEM |
INJECTABLE;INJECTION |
1GM/VIAL |
Prescription |
No |
No |
AP |
2024/07/22
|
QILU |
活性成分:MEROPENEM 剂型/给药途径:INJECTABLE;INJECTION 规格:500MG/VIAL 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
050706 |
003 |
NDA |
MERREM |
MEROPENEM |
INJECTABLE;INJECTION |
500MG/VIAL |
Prescription |
Yes |
Yes |
AP |
1996/06/21
|
PFIZER |
091404 |
001 |
ANDA |
MEROPENEM |
MEROPENEM |
INJECTABLE;INJECTION |
500MG/VIAL |
Prescription |
No |
No |
AP |
2011/10/26
|
ACS DOBFAR |
204854 |
001 |
ANDA |
MEROPENEM |
MEROPENEM |
INJECTABLE;INJECTION |
500MG/VIAL |
Discontinued |
No |
No |
AP |
2015/12/18
|
DAEWOONG PHARM CO |
205883 |
001 |
ANDA |
MEROPENEM |
MEROPENEM |
INJECTABLE;INJECTION |
500MG/VIAL |
Prescription |
No |
No |
AP |
2016/04/12
|
AMNEAL PHARMS |
206086 |
001 |
ANDA |
MEROPENEM |
MEROPENEM |
INJECTABLE;INJECTION |
500MG/VIAL |
Prescription |
No |
No |
AP |
2016/04/19
|
SAVIOR LIFETEC CORP |
206141 |
001 |
ANDA |
MEROPENEM |
MEROPENEM |
INJECTABLE;INJECTION |
500MG/VIAL |
Prescription |
No |
No |
AP |
2016/06/08
|
GLAND |
204139 |
001 |
ANDA |
MEROPENEM |
MEROPENEM |
INJECTABLE;INJECTION |
500MG/VIAL |
Prescription |
No |
No |
AP |
2016/06/09
|
ACS DOBFAR SPA |
205835 |
001 |
ANDA |
MEROPENEM |
MEROPENEM |
INJECTABLE;INJECTION |
500MG/VIAL |
Prescription |
No |
No |
AP |
2017/03/27
|
EUGIA PHARMA |
210773 |
001 |
ANDA |
MEROPENEM |
MEROPENEM |
INJECTABLE;INJECTION |
500MG/VIAL |
Prescription |
No |
No |
AP |
2019/08/16
|
HQ SPCLT PHARMA |
216154 |
001 |
ANDA |
MEROPENEM |
MEROPENEM |
INJECTABLE;INJECTION |
500MG/VIAL |
Prescription |
No |
No |
AP |
2022/08/18
|
BROOKS STERISCIENCE |
216424 |
001 |
ANDA |
MEROPENEM |
MEROPENEM |
INJECTABLE;INJECTION |
500MG/VIAL |
Prescription |
No |
No |
AP |
2024/07/22
|
QILU |